A very important potential breakthrough that uses an HIV drug, preapproved by the FDA, to block metastases in PCa. In a study published online in the journal Cancer Research, researchers show that the receptor CCR5 best known for its role in HIV therapy, may also be involved in driving the spread of prostate cancer to the bone. Article #2 states conventional treatment seeks to eradicate cancer cells by drugs and therapy delivered from outside the cell, which may also affect (and potentially harm) nearby normal cells.
1) Bone metastases in prostate cancer blocked by HIV drug (2 December 2014)
“This work shows we can dramatically reduce metastasis in pre-clinical models, and because the drug is already FDA approved for HIV treatment- we may be able to test soon whether this drug can block metastasis in patients with prostate cancer,” says Richard Pestell, M.D., Ph.D., MBA, Director of the Sidney Kimmel Cancer Center at Thomas Jefferson University and senior author on the study”. Full Story:” Bone metastases in prostate cancer blocked by HIV drug2) Newly designed nanoparticles infiltrate, kill cancer cells from within (26 November 2014 ) “In contrast to conventional cancer therapy, a University of Cincinnati team has developed several novel designs for iron-oxide based nanoparticles that detect, diagnose and destroy cancer cells using photo-thermal therapy (PTT)”. CELL TARGETING, ” Each tumor has a corresponding protein that is cancer specific called a tumor specific ligand or an antibody antigen reaction that only has expression for that specific cancer such as breast or prostate cancer“. Full Story:” New Nanoparticle Created for Cancer Therapy God’s Greatest Gift is TIME! Craig BeckerThe New Denver Men’s Club
Blog: https://newdenvermensclub.wordpress.com/ “Men Fighting Cancer To Win”
You can read all my posts at the blog site by clicking here